The pact would entail the Indian company receiving up to $38 million (over Rs 165 crore).
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
Takeda had filed a case of patent infringement in response to Zydus' abbreviated new drug application.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances